Osteoporosis prevalence and associated factors in patients with COPD: A cross-sectional study

Respiratory Care

Volumn 56, Issue 7, 2011, Pages 961-968

  Silva, Denise Rossato ^a   Coelho, Ana Cláudia ^a   Dumke, Anelise ^a   Valentini, Jorge Diego ^a   de Nunes, Juliana Nunes ^a   Stefani, Clarisse Luisa ^a   Mendes, Lívia Fontes da Silva ^a   Knorst, Marli Maria ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bone loss; COPD; Corticosteroids; Osteopenia; Osteoporosis

Indexed keywords

CALCIUM; CARBON MONOXIDE; CORTICOSTEROID; VITAMIN D;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODE INDEX; BODY MASS; BONE DENSITY; BONE MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRACTURE; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INSPIRATORY CAPACITY; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; LUMBAR SPINE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; OUTPATIENT; PHYSICAL ACTIVITY; PREVALENCE; QUESTIONNAIRE; SCORING SYSTEM; SMOKING; TOTAL LUNG CAPACITY; TREATMENT DURATION;

ABSORPTIOMETRY, PHOTON; ADRENAL CORTEX HORMONES; AGED; BODY MASS INDEX; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 79960686149     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01056     Document Type: Article

References (47)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343(4):269-278.
2. Stone AC, Nici L. Other systemic manifestations of chronic obstructive pulmonary disease. Clin Chest Med 2007;28(3):553-555.
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165-1185.
4. World Health organization (WHO). Prevention and management of osteoporosis: report of a WHO scientific group. http://whqlibdoc.who.int/trs/WHOTRS921.pdf. Accessed May 10, 2011.
5. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175(12):1259-1265.
6. Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170(12):1286-1293.
7. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101(3):262-269.
8. Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000;94(11):1079-1084.
9. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116(6):1616-1624.
10. Kjensli A, Mowinckel P, Ryg MS. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007;40(2):493-497.
11. Vrieze A, de Greef MH, Wykstra PJ. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteopor Int 2007;18(9):1197-1202.
12. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary. GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
13. Laranjeira R, Pinsky I. O alcoolismo. In: Laranjeira R, Pinsky I, editors. O alcoolismo. Mitos e verdades. São Paulo, Brazil: Contexto; 2000;1. Book in Portugese.
14. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. http://whqlibdoc.who.int/trs/WHO_TRS_843.pdf. Accessed May 10, 2011.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization on spirometry. Eur Respir J 2005;26(2): 319-338.
16. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardization of measurement of lung volumes. Eur Respir J 2005;26(3):511-522.
17. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardization of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720-735.
18. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123(6):659-664.
19. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy non-smoking adults. Bulletin European de Physiopathologie Respiratoire 1982;18(3):419-425.
20. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusion capacity.AmRev Respir Dis 1981;123(2): 185-189.
21. Mahler D, Wells C. Evaluation of clinical methods of rating dyspnea. Chest 1988;93(3):580-586.
22. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
23. Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999; 69(2):243-249.
24. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded selfadministered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135(10): 1114-1126.
25. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(9 Suppl):S498-S504.
26. Fitzpatrick TB. Soleil et peau. J Med Esthet 1975;3(1):33-34. Article in French.
27. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007;101(1):177-185.
28. Vries F, Staa TP, Bracke MSGM, Cooper C, Leufkens HGM, Lammers JWJ. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005;25(5):879-884.
29. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 2003;22(Suppl 46):64S-75S.
30. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009;34(1):209-218.
31. Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF; CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med 2009;103(8):1143-1151.
32. Kiel DP, Zhang Y, Hannan MT, Anderson JJ, Baron JA, Felson DT. The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 1996;6(3):240-248.
33. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997;315(7112):841-846.
34. Wong PKK, Christie JJ, Wark JD. The effects of smoking on bone health. Clin Sci 2007;113(5):233-241.
35. Cooper C, Barker DJ, Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ 1988;297(6661):1443-1446.
36. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332(12):767-773.
37. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8(5):468-489.
38. Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 2005;20(2):185-194.
39. Li L, Brennan KJ, Gaughan JP, Ciccolella DE, Kuzma AM, Criner GJ. African-Americans and men with severe COPD have a high prevalence of osteoporosis. COPD 2008;5(5):291-297.
40. Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R, Crepaldi G. Osteoporosis risk in patients with chronic obstructive pulmonary disease: The EOLO study. J Clin Densitom 2009;12(3):345-352.
41. Goldstein JL, Fallon JJ Jr, Harning R. Chronic glucocorticoid therapy- induced osteoporosis in patients with obstructive lung disease. Chest 1999;116(6):1733-1749.
42. Ip M, Lam K, Yam L. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105(6):1722-1727.
43. Biskobing DM. COPD and osteoporosis. Chest 2002;121(2):609-620.
44. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev;2002(1): CD003537.
45. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59(7): 574-580.
46. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-1688S.
47. McCarty CA. Sunlight exposure assessment: can we accurately assess vitamin D exposure from sunlight questionnaires? Am J Clin Nutr 2008;87(4):1097S-1101S.